CAPTRUST Financial Advisors’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-43
Closed -$2K 5136
2022
Q1
$2K Buy
43
+36
+514% +$1.67K ﹤0.01% 4542
2021
Q4
$1K Buy
+7
New +$1K ﹤0.01% 4631